Hardware, Equipment & Parts
Compare Stocks
5 / 10Stock Comparison
ITRI vs REZI vs TRMB vs LDOS vs ACLX
Revenue, margins, valuation, and 5-year total return — side by side.
Security & Protection Services
Hardware, Equipment & Parts
Information Technology Services
Biotechnology
ITRI vs REZI vs TRMB vs LDOS vs ACLX — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Hardware, Equipment & Parts | Security & Protection Services | Hardware, Equipment & Parts | Information Technology Services | Biotechnology |
| Market Cap | $3.60B | $6.04B | $14.65B | $16.51B | $6.73B |
| Revenue (TTM) | $2.35B | $7.47B | $3.69B | $17.48B | $22M |
| Net Income (TTM) | $289M | $-527M | $456M | $1.36B | $-229M |
| Gross Margin | 38.6% | 29.4% | 68.8% | 17.3% | -64.8% |
| Operating Margin | 13.2% | 8.1% | 17.7% | 11.6% | -11.4% |
| Forward P/E | 13.5x | 13.1x | 20.0x | 11.1x | — |
| Total Debt | $1.29B | $3.17B | $1.39B | $5.93B | $96M |
| Cash & Equiv. | $1.02B | $661M | $253M | $1.20B | $80M |
ITRI vs REZI vs TRMB vs LDOS vs ACLX — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Feb 22 | May 26 | Return |
|---|---|---|---|
| Itron, Inc. (ITRI) | 100 | 170.2 | +70.2% |
| Resideo Technologie… (REZI) | 100 | 156.4 | +56.4% |
| Trimble Inc. (TRMB) | 100 | 88.7 | -11.3% |
| Leidos Holdings, In… (LDOS) | 100 | 128.8 | +28.8% |
| Arcellx, Inc. (ACLX) | 100 | 599.9 | +499.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ITRI vs REZI vs TRMB vs LDOS vs ACLX
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Among these 5 stocks, ITRI doesn't own a clear edge in any measured category.
REZI is the #2 pick in this set and the best alternative if growth is your priority.
- 10.5% revenue growth vs ACLX's -79.4%
TRMB ranks third and is worth considering specifically for sleep-well-at-night.
- Lower volatility, beta 1.46, Low D/E 23.9%, current ratio 1.09x
- 12.4% margin vs ACLX's -10.3%
LDOS carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 5 yrs, beta 0.42, yield 1.2%
- Rev growth 3.1%, EPS growth 20.7%, 3Y rev CAGR 6.1%
- PEG 0.54 vs TRMB's 8.15
- Beta 0.42, yield 1.2%, current ratio 1.70x
ACLX is the clearest fit if your priority is long-term compounding.
- 5.8% 10Y total return vs LDOS's 223.8%
- +117.4% vs ITRI's -23.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 10.5% revenue growth vs ACLX's -79.4% | |
| Value | Better valuation composite | |
| Quality / Margins | 12.4% margin vs ACLX's -10.3% | |
| Stability / Safety | Beta 0.42 vs REZI's 2.27 | |
| Dividends | 1.2% yield, 5-year raise streak, vs REZI's 0.6%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +117.4% vs ITRI's -23.7% | |
| Efficiency (ROA) | 9.4% ROA vs ACLX's -36.2%, ROIC 17.1% vs -46.2% |
ITRI vs REZI vs TRMB vs LDOS vs ACLX — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
ITRI vs REZI vs TRMB vs LDOS vs ACLX — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
LDOS leads in 3 of 6 categories
ACLX leads 2 • TRMB leads 1 • ITRI leads 0 • REZI leads 0
Explore the data ↓Income & Cash Flow (Last 12 Months)
TRMB leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
LDOS is the larger business by revenue, generating $17.5B annually — 784.2x ACLX's $22M. TRMB is the more profitable business, keeping 12.4% of every revenue dollar as net income compared to ACLX's -10.3%. On growth, TRMB holds the edge at +11.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $2.3B | $7.5B | $3.7B | $17.5B | $22M |
| EBITDAEarnings before interest/tax | $367M | $802M | $785M | $2.2B | -$246M |
| Net IncomeAfter-tax profit | $289M | -$527M | $456M | $1.4B | -$229M |
| Free Cash FlowCash after capex | $393M | -$1.3B | $253M | $1.7B | -$213M |
| Gross MarginGross profit ÷ Revenue | +38.6% | +29.4% | +68.8% | +17.3% | -64.8% |
| Operating MarginEBIT ÷ Revenue | +13.2% | +8.1% | +17.7% | +11.6% | -11.4% |
| Net MarginNet income ÷ Revenue | +12.3% | -7.1% | +12.4% | +7.8% | -10.3% |
| FCF MarginFCF ÷ Revenue | +16.7% | -16.8% | +6.9% | +9.6% | -9.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | -3.3% | +2.0% | +11.8% | +3.7% | -89.2% |
| EPS Growth (YoY)Latest quarter vs prior year | -16.9% | +11.4% | +55.6% | -7.6% | -13.6% |
Valuation Metrics
LDOS leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 11.8x trailing earnings, LDOS trades at a 67% valuation discount to TRMB's 35.3x P/E. Adjusting for growth (PEG ratio), LDOS offers better value at 0.57x vs TRMB's 14.39x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $3.6B | $6.0B | $14.7B | $16.5B | $6.7B |
| Enterprise ValueMkt cap + debt − cash | $3.9B | $8.5B | $15.8B | $21.2B | $6.7B |
| Trailing P/EPrice ÷ TTM EPS | 12.46x | -10.68x | 35.34x | 11.79x | -28.27x |
| Forward P/EPrice ÷ next-FY EPS est. | 13.47x | 13.07x | 20.01x | 11.08x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | 14.39x | 0.57x | — |
| EV / EBITDAEnterprise value multiple | 10.48x | 10.65x | 20.05x | 8.82x | — |
| Price / SalesMarket cap ÷ Revenue | 1.52x | 0.81x | 4.08x | 0.96x | 302.09x |
| Price / BookPrice ÷ Book value/share | 2.15x | 2.06x | 2.54x | 3.50x | 16.10x |
| Price / FCFMarket cap ÷ FCF | 9.44x | — | 110.00x | 10.16x | — |
Profitability & Efficiency
LDOS leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
LDOS delivers a 27.1% return on equity — every $100 of shareholder capital generates $27 in annual profit, vs $-55 for ACLX. TRMB carries lower financial leverage with a 0.24x debt-to-equity ratio, signaling a more conservative balance sheet compared to LDOS's 1.19x. On the Piotroski fundamental quality scale (0–9), LDOS scores 8/9 vs ACLX's 1/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +17.2% | -18.1% | +8.0% | +27.1% | -55.4% |
| ROA (TTM)Return on assets | +7.7% | -6.2% | +5.0% | +9.4% | -36.2% |
| ROICReturn on invested capital | +13.1% | +9.0% | +6.8% | +17.1% | -46.2% |
| ROCEReturn on capital employed | +11.4% | +9.3% | +7.8% | +21.0% | -46.6% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 4 | 5 | 8 | 1 |
| Debt / EquityFinancial leverage | 0.74x | 1.09x | 0.24x | 1.19x | 0.24x |
| Net DebtTotal debt minus cash | $267M | $2.5B | $1.1B | $4.7B | $16M |
| Cash & Equiv.Liquid assets | $1.0B | $661M | $253M | $1.2B | $80M |
| Total DebtShort + long-term debt | $1.3B | $3.2B | $1.4B | $5.9B | $96M |
| Interest CoverageEBIT ÷ Interest expense | 14.38x | -2.36x | 12.26x | 9.91x | -8.45x |
Total Returns (Dividends Reinvested)
ACLX leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ACLX five years ago would be worth $68,494 today (with dividends reinvested), compared to $7,797 for TRMB. Over the past 12 months, ACLX leads with a +117.4% total return vs ITRI's -23.7%. The 3-year compound annual growth rate (CAGR) favors ACLX at 38.6% vs ITRI's 6.5% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -14.1% | +14.5% | -21.0% | -28.2% | +81.7% |
| 1-Year ReturnPast 12 months | -23.7% | +111.6% | -6.7% | -14.1% | +117.4% |
| 3-Year ReturnCumulative with dividends | +20.8% | +145.5% | +30.1% | +71.9% | +166.2% |
| 5-Year ReturnCumulative with dividends | -7.2% | +33.0% | -22.0% | +33.4% | +584.9% |
| 10-Year ReturnCumulative with dividends | +94.4% | +38.9% | +166.8% | +223.8% | +584.9% |
| CAGR (3Y)Annualised 3-year return | +6.5% | +34.9% | +9.2% | +19.8% | +38.6% |
Risk & Volatility
ACLX leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
ACLX is the less volatile stock with a -0.34 beta — it tends to amplify market swings less than REZI's 2.27 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ACLX currently trades 99.9% from its 52-week high vs ITRI's 57.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.53x | 2.27x | 1.46x | 0.42x | -0.34x |
| 52-Week HighHighest price in past year | $142.00 | $45.29 | $87.50 | $205.77 | $115.13 |
| 52-Week LowLowest price in past year | $78.53 | $18.88 | $61.63 | $129.35 | $47.86 |
| % of 52W HighCurrent price vs 52-week peak | +57.1% | +88.9% | +70.7% | +63.8% | +99.9% |
| RSI (14)Momentum oscillator 0–100 | 35.2 | 61.4 | 36.8 | 24.5 | 79.9 |
| Avg Volume (50D)Average daily shares traded | 893K | 1.1M | 1.7M | 1.0M | 1.6M |
Analyst Outlook
LDOS leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: ITRI as "Hold", REZI as "Buy", TRMB as "Buy", LDOS as "Buy", ACLX as "Hold". Consensus price targets imply 68.8% upside for ITRI (target: $137) vs -2.3% for ACLX (target: $112). For income investors, LDOS offers the higher dividend yield at 1.21% vs REZI's 0.58%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $137.00 | $40.00 | $95.00 | $204.00 | $112.45 |
| # AnalystsCovering analysts | 37 | 7 | 28 | 27 | 18 |
| Dividend YieldAnnual dividend ÷ price | — | +0.6% | — | +1.2% | — |
| Dividend StreakConsecutive years of raises | 1 | 2 | — | 5 | — |
| Dividend / ShareAnnual DPS | — | $0.23 | — | $1.59 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +2.8% | 0.0% | +5.9% | +5.7% | 0.0% |
LDOS leads in 3 of 6 categories (Valuation Metrics, Profitability & Efficiency). ACLX leads in 2 (Total Returns, Risk & Volatility).
ITRI vs REZI vs TRMB vs LDOS vs ACLX: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ITRI or REZI or TRMB or LDOS or ACLX a better buy right now?
For growth investors, Resideo Technologies, Inc.
(REZI) is the stronger pick with 10. 5% revenue growth year-over-year, versus -79. 4% for Arcellx, Inc. (ACLX). Leidos Holdings, Inc. (LDOS) offers the better valuation at 11. 8x trailing P/E (11. 1x forward), making it the more compelling value choice. Analysts rate Resideo Technologies, Inc. (REZI) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ITRI or REZI or TRMB or LDOS or ACLX?
On trailing P/E, Leidos Holdings, Inc.
(LDOS) is the cheapest at 11. 8x versus Trimble Inc. at 35. 3x. On forward P/E, Leidos Holdings, Inc. is actually cheaper at 11. 1x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Leidos Holdings, Inc. wins at 0. 54x versus Trimble Inc. 's 8. 15x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — ITRI or REZI or TRMB or LDOS or ACLX?
Over the past 5 years, Arcellx, Inc.
(ACLX) delivered a total return of +584. 9%, compared to -22. 0% for Trimble Inc. (TRMB). Over 10 years, the gap is even starker: ACLX returned +584. 9% versus REZI's +38. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ITRI or REZI or TRMB or LDOS or ACLX?
By beta (market sensitivity over 5 years), Arcellx, Inc.
(ACLX) is the lower-risk stock at -0. 34β versus Resideo Technologies, Inc. 's 2. 27β — meaning REZI is approximately -773% more volatile than ACLX relative to the S&P 500. On balance sheet safety, Trimble Inc. (TRMB) carries a lower debt/equity ratio of 24% versus 119% for Leidos Holdings, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — ITRI or REZI or TRMB or LDOS or ACLX?
By revenue growth (latest reported year), Resideo Technologies, Inc.
(REZI) is pulling ahead at 10. 5% versus -79. 4% for Arcellx, Inc. (ACLX). On earnings-per-share growth, the picture is similar: Itron, Inc. grew EPS 25. 7% year-over-year, compared to -718. 0% for Resideo Technologies, Inc.. Over a 3-year CAGR, ITRI leads at 9. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ITRI or REZI or TRMB or LDOS or ACLX?
Itron, Inc.
(ITRI) is the more profitable company, earning 12. 7% net margin versus -1027. 3% for Arcellx, Inc. — meaning it keeps 12. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: TRMB leads at 16. 9% versus -1135. 6% for ACLX. At the gross margin level — before operating expenses — ACLX leads at 70. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ITRI or REZI or TRMB or LDOS or ACLX more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Leidos Holdings, Inc. (LDOS) is the more undervalued stock at a PEG of 0. 54x versus Trimble Inc. 's 8. 15x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Leidos Holdings, Inc. (LDOS) trades at 11. 1x forward P/E versus 20. 0x for Trimble Inc. — 8. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ITRI: 68. 8% to $137. 00.
08Which pays a better dividend — ITRI or REZI or TRMB or LDOS or ACLX?
In this comparison, LDOS (1.
2% yield), REZI (0. 6% yield) pay a dividend. ITRI, TRMB, ACLX do not pay a meaningful dividend and should not be held primarily for income.
09Is ITRI or REZI or TRMB or LDOS or ACLX better for a retirement portfolio?
For long-horizon retirement investors, Arcellx, Inc.
(ACLX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 34), +584. 9% 10Y return). Itron, Inc. (ITRI) carries a higher beta of 1. 53 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ACLX: +584. 9%, ITRI: +94. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ITRI and REZI and TRMB and LDOS and ACLX?
These companies operate in different sectors (ITRI (Technology) and REZI (Industrials) and TRMB (Technology) and LDOS (Technology) and ACLX (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: ITRI is a small-cap deep-value stock; REZI is a small-cap quality compounder stock; TRMB is a mid-cap quality compounder stock; LDOS is a mid-cap deep-value stock; ACLX is a small-cap quality compounder stock. REZI, LDOS pay a dividend while ITRI, TRMB, ACLX do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.